Chemical formula: C₁₁H₁₃BrN₂O₅  Molecular mass: 333.135 g/mol  PubChem compound: 446727

Active ingredient description

Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster in adult patients. Brivudine is incorporated into the viral DNA and blocks the action of DNA polymerases, thus inhibiting viral replication.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AB15 Brivudine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB15

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 69304-47-8
DrugBank Drug: DB03312
PubChem Compound: 446727
RxNorm Ingredient: 59161
SNOMED-CT Concept: 698049003
Brivudine (substance)
UNII Identifier: 2M3055079H


Brivudine is an active ingredient of these brands:

Austria (AT)

Estonia (EE)

Italy (IT)

Lithuania (LT)

Romania (RO)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.